Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

David S. Lawrence; Nabila Youssouf; Síle F. Molloy; Alexandre Alanio; Melanie Alufandika; David R. Boulware; Timothée Boyer-Chammard; Tao Chen; Francoise Dromer; Admire Hlupeni; William Hope; Mina C. Hosseinipour; Cecilia Kanyama; Oliver Lortholary; Angela Loyse; David B. Meya; Mosepele Mosepele; Conrad Muzoora; Henry C. Mwandumba; Chiratidzo E. Ndhlovu; Louis Niessen; Charlotte Schutz; Katharine E. Stott; Duolao Wang; David G. Lalloo; Graeme Meintjes; Shabbar Jaffar; Thomas S. Harrison; Joseph N. Jarvis

doi:10.1186/s13063-018-3155-9

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

David S. Lawrence
, Nabila Youssouf
, Síle F. Molloy
, Alexandre Alanio
, Melanie Alufandika
, David R. Boulware
, Timothée Boyer-Chammard
, Tao Chen
, Francoise Dromer
, Admire Hlupeni
, William Hope
, Mina C. Hosseinipour
, Cecilia Kanyama
, Oliver Lortholary
, Angela Loyse
, David B. Meya
, Mosepele Mosepele
, Conrad Muzoora
, Henry C. Mwandumba
, Chiratidzo E. Ndhlovu

Louis Niessen, Charlotte Schutz, Katharine E. Stott, Duolao Wang, David G. Lalloo, Graeme Meintjes, Shabbar Jaffar, Thomas S. Harrison, Joseph N. Jarvis

Medicine - Infectious Disease and International Medicine

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

Original language	English (US)
Article number	48
Journal	Trials
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13063-018-3155-9
State	Published - Jan 14 2019

Bibliographical note

Publisher Copyright:
© 2019 The Author(s).

PubMed: MeSH publication types

Published Erratum
Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1186/s13063-018-3155-9

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)'. Together they form a unique fingerprint.

Cite this

Lawrence, D. S., Youssouf, N., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., Boyer-Chammard, T., Chen, T., Dromer, F., Hlupeni, A., Hope, W., Hosseinipour, M. C., Kanyama, C., Lortholary, O., Loyse, A., Meya, D. B., Mosepele, M., Muzoora, C., Mwandumba, H. C., ... Jarvis, J. N. (2019). Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). Trials, 20(1), Article 48. https://doi.org/10.1186/s13063-018-3155-9

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). / Lawrence, David S.; Youssouf, Nabila; Molloy, Síle F. et al.
In: Trials, Vol. 20, No. 1, 48, 14.01.2019.

Research output: Contribution to journal › Comment/debate › peer-review

Lawrence, DS, Youssouf, N, Molloy, SF, Alanio, A, Alufandika, M, Boulware, DR, Boyer-Chammard, T, Chen, T, Dromer, F, Hlupeni, A, Hope, W, Hosseinipour, MC, Kanyama, C, Lortholary, O, Loyse, A, Meya, DB, Mosepele, M, Muzoora, C, Mwandumba, HC, Ndhlovu, CE, Niessen, L, Schutz, C, Stott, KE, Wang, D, Lalloo, DG, Meintjes, G, Jaffar, S, Harrison, TS & Jarvis, JN 2019, 'Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)', Trials, vol. 20, no. 1, 48. https://doi.org/10.1186/s13063-018-3155-9

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR et al. Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9

Lawrence, David S. ; Youssouf, Nabila ; Molloy, Síle F. et al. / Correction : AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4). In: Trials. 2019 ; Vol. 20, No. 1.

@article{803f17e4dcb74376a11c9d9204504150,

title = "Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)",

abstract = "Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.",

author = "Lawrence, \{David S.\} and Nabila Youssouf and Molloy, \{S{\'i}le F.\} and Alexandre Alanio and Melanie Alufandika and Boulware, \{David R.\} and Timoth{\'e}e Boyer-Chammard and Tao Chen and Francoise Dromer and Admire Hlupeni and William Hope and Hosseinipour, \{Mina C.\} and Cecilia Kanyama and Oliver Lortholary and Angela Loyse and Meya, \{David B.\} and Mosepele Mosepele and Conrad Muzoora and Mwandumba, \{Henry C.\} and Ndhlovu, \{Chiratidzo E.\} and Louis Niessen and Charlotte Schutz and Stott, \{Katharine E.\} and Duolao Wang and Lalloo, \{David G.\} and Graeme Meintjes and Shabbar Jaffar and Harrison, \{Thomas S.\} and Jarvis, \{Joseph N.\}",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s).",

year = "2019",

month = jan,

day = "14",

doi = "10.1186/s13063-018-3155-9",

language = "English (US)",

volume = "20",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

AU - Lawrence, David S.

AU - Youssouf, Nabila

AU - Molloy, Síle F.

AU - Alanio, Alexandre

AU - Alufandika, Melanie

AU - Boulware, David R.

AU - Boyer-Chammard, Timothée

AU - Chen, Tao

AU - Dromer, Francoise

AU - Hlupeni, Admire

AU - Hope, William

AU - Hosseinipour, Mina C.

AU - Kanyama, Cecilia

AU - Lortholary, Oliver

AU - Loyse, Angela

AU - Meya, David B.

AU - Mosepele, Mosepele

AU - Muzoora, Conrad

AU - Mwandumba, Henry C.

AU - Ndhlovu, Chiratidzo E.

AU - Niessen, Louis

AU - Schutz, Charlotte

AU - Stott, Katharine E.

AU - Wang, Duolao

AU - Lalloo, David G.

AU - Meintjes, Graeme

AU - Jaffar, Shabbar

AU - Harrison, Thomas S.

AU - Jarvis, Joseph N.

PY - 2019/1/14

Y1 - 2019/1/14

N2 - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

AB - Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected. Originally published name: Sile L F Molloy Correct name: Sile F Molloy.

UR - https://www.scopus.com/pages/publications/85059985577

UR - https://www.scopus.com/pages/publications/85059985577#tab=citedBy

U2 - 10.1186/s13063-018-3155-9

DO - 10.1186/s13063-018-3155-9

M3 - Comment/debate

C2 - 30642386

AN - SCOPUS:85059985577

SN - 1745-6215

VL - 20

JO - Trials

JF - Trials

IS - 1

M1 - 48

ER -

Correction: AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Study protocol for a phase 3 randomised controlled non-inferiority trial (Trials (2018) 19 (649) DOI: 10.1186/s13063-018-3026-4)

Abstract

Bibliographical note

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this